Author:
Guerrieri C.,Jobbagy Z.,Hudacko R.
Subject
Pathology and Forensic Medicine
Reference5 articles.
1. Herawi M, De Marzo A, Kristiansen G, et al.
Expression of CDX2 in benign tissue and adenocarcinoma of the
prostate. Hum Pathol 2007;38;72-8.
https://doi.org/10.1016/j.humpath.2006.06.015
2. Leite KRM, Mitteldorf C, Srougi M, et al.
Cdx2, cytokeratin 20, thyroid transcription factor and
prostate-specific antigen expression in unusual subtypes of prostate
cancer. Ann Diagn Pathol 2008;12;260-6.
https://doi.org/10.1016/j.anndiagpath.2007.11.001.
3. Nwankwo N, Mirrakhimov AE, Zdunek T, et al.
Prostate adenocarcinoma with a rectal metastasis. BMJ Case Rep
2013;2013.
https://doi.org/10.1136/bcr-2013-009503.
4. Owens CL, Epstein JI, Netto GJ.
Distinguishing prostatic from colorectal adenocarcinoma on biopsy
samples: the role of morphology and immunohistochemistry. Arch
Pathol Lab Med 2007;131;599-603.
https://doi.org/10.1043/1543-2165(2007)131[599:DPFCAO]2.0.CO;2
5. Saad RS, Ghorab Z, Khalifa MA, Xu M. CDX2
as a marker for intestinal differentiation: its utility and
limitations. World J Gastrointest Surg 2011;27;159-66.
https://doi.org/10.4240/wjgs.v3.i11.159.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献